All Stories

  1. Safety concerns with the Centers for Disease Control opioid calculator

    Article • Journal of Pain Research, December 2017, Dove Medical Press

    Dr Jeffrey Fudin, Dr. Erica L. Wegrzyn, Dr Michael E. Schatman

  2. Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes

    Article • Journal of Pain Research, December 2017, Dove Medical Press

    Dr Michael E. Schatman, Dr. Erica L. Wegrzyn, Lisa Dragic, Dr Jeffrey Fudin

  3. Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease

    Article • Journal of Pain Research, December 2016, Dove Medical Press

    Dr. Erica L. Wegrzyn, Jeffrey Bettinger, Dr Jeffrey Fudin

  4. OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form

    Article • Journal of Pain Research, September 2016, Dove Medical Press

    Dr Jeffrey Fudin, Dr. Erica L. Wegrzyn